IRIS
VIGNERI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.924
EU - Europa 6.601
AS - Asia 6.112
SA - Sud America 1.020
AF - Africa 756
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 25.433
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.535
SG - Singapore 2.943
RU - Federazione Russa 2.062
IT - Italia 1.675
CN - Cina 1.494
BR - Brasile 855
IE - Irlanda 771
UA - Ucraina 588
VN - Vietnam 475
IN - India 470
CI - Costa d'Avorio 381
DE - Germania 311
CA - Canada 293
FR - Francia 283
KR - Corea 221
GB - Regno Unito 178
NL - Olanda 161
NG - Nigeria 132
SE - Svezia 117
SN - Senegal 116
BE - Belgio 111
FI - Finlandia 91
BD - Bangladesh 75
AR - Argentina 67
MX - Messico 65
IQ - Iraq 63
PL - Polonia 60
JP - Giappone 57
ES - Italia 43
HK - Hong Kong 41
CZ - Repubblica Ceca 37
TR - Turchia 35
UZ - Uzbekistan 35
ZA - Sudafrica 33
IR - Iran 27
BJ - Benin 24
CH - Svizzera 24
AE - Emirati Arabi Uniti 22
EC - Ecuador 22
VE - Venezuela 22
PK - Pakistan 21
CO - Colombia 20
ID - Indonesia 20
KE - Kenya 20
AT - Austria 17
GR - Grecia 17
SA - Arabia Saudita 17
MA - Marocco 14
IL - Israele 13
LB - Libano 12
MY - Malesia 12
CL - Cile 11
TN - Tunisia 11
AU - Australia 10
LT - Lituania 10
EG - Egitto 9
OM - Oman 9
PY - Paraguay 8
RO - Romania 8
AZ - Azerbaigian 7
BG - Bulgaria 7
JM - Giamaica 7
KZ - Kazakistan 7
RS - Serbia 7
AL - Albania 6
JO - Giordania 6
PH - Filippine 6
CR - Costa Rica 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
PE - Perù 5
PS - Palestinian Territory 5
UY - Uruguay 5
BO - Bolivia 4
EU - Europa 4
HU - Ungheria 4
NP - Nepal 4
ET - Etiopia 3
GA - Gabon 3
KG - Kirghizistan 3
NI - Nicaragua 3
NO - Norvegia 3
TT - Trinidad e Tobago 3
BY - Bielorussia 2
CG - Congo 2
HR - Croazia 2
LK - Sri Lanka 2
MN - Mongolia 2
PR - Porto Rico 2
SV - El Salvador 2
TH - Thailandia 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BW - Botswana 1
CM - Camerun 1
Totale 25.418
Salva come PNG Salva come JPEG
Città #
Dallas 1.838
Singapore 1.792
Santa Clara 1.384
Moscow 932
Chandler 840
Dublin 770
San Jose 742
Jacksonville 646
Ashburn 585
Chicago 528
Catania 438
Abidjan 381
Boardman 342
Kochi 337
Hefei 335
Los Angeles 235
Lauterbourg 227
Seoul 220
Cambridge 206
Lawrence 203
Nanjing 200
Beijing 198
Andover 193
Toronto 166
New York 150
Ho Chi Minh City 148
Grafing 134
Dakar 116
Hanoi 114
Des Moines 111
Council Bluffs 110
San Mateo 100
Civitanova Marche 98
Buffalo 87
Wilmington 86
São Paulo 83
Milan 70
Rotterdam 65
Lagos 64
Palermo 64
Munich 63
Orem 63
Abuja 60
Tokyo 56
Ottawa 55
Rome 53
Nanchang 51
Wingene 50
Warsaw 48
Hebei 47
Shenyang 45
Lappeenranta 43
Montreal 43
Chennai 42
Dong Ket 40
Bari 39
Brooklyn 38
Saint Petersburg 38
Brussels 37
Hong Kong 37
Seattle 36
Bremen 34
Houston 34
Portland 33
Amsterdam 32
Poplar 32
The Dalles 32
Changsha 30
Columbus 30
Jiaxing 30
Rio de Janeiro 30
Phoenix 29
Baghdad 28
Brno 28
Atlanta 26
Falls Church 26
Johannesburg 26
London 26
Tianjin 26
Boston 25
Denver 25
Turku 25
Cotonou 24
Manchester 23
Mexico City 23
San Giovanni la Punta 23
Stockholm 23
Helsinki 22
Frankfurt am Main 21
San Francisco 21
Belo Horizonte 20
Tashkent 20
Messina 19
Pune 19
Brasília 17
Florence 17
Da Nang 16
Dhaka 16
Haiphong 16
Quintano 16
Totale 17.285
Salva come PNG Salva come JPEG
Nome #
148P The impact of chemotherapy relative dose intensity on pathological complete response and event-free survival in patients with triple-negative breast cancer treated with neoadjuvant chemotherapy 262
A Custom DNA-Based NGS Panel for the Molecular Characterization of Patients With Diffuse Gliomas: Diagnostic and Therapeutic Applications 243
Novel mechanisms of tumor promotion by the insulin receptor isoform a in triple-negative breast cancer cells 237
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib 227
A Case of Non-Irradiated Balloon Cell Melanoma of the Choroid: Expanding the Morphological Spectrum of Primary Uveal Melanomas 225
Correlation between weight and Recurrence Score in a cohort of HR+ve/ HER2-ve early breast cancer patients: a retrospective analysis 215
Concordance between CDKN2A homozygous deletion and MTAP immunohistochemical loss in fluoroedenite-induced pleural mesothelioma: An immunohistochemical and molecular study on a single-institution series 200
Activation of the IGF axis in thyroid cancer: Implications for tumorigenesis and treatment 184
Effect of low-dose tungsten on human thyroid stem/precursor cells and their progeny 177
AKT Inhibitors: New Weapons in the Fight Against Breast Cancer? 173
DDR1 regulates thyroid cancer cell differentiation via IGF-2/IR-A autocrine signaling loop 172
An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal Melanoma 170
BCR-ABL1 doubling-times and halving-times may predict CML response to tyrosine kinase inhibitors 169
High BCR-ABL/GUSISlevels at diagnosis of chronic phase CML are associated with unfavorable responses to standard-dose imatinib 168
Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the MPL Gene: Two Case Reports 167
Anaplastic thyroid cancer in sicily: The role of environmental characteristics. 165
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53 164
Biomarkers and prognostic factors for malignant pleural mesothelioma 163
Comparative proteomic analysis of insulin receptor isoform A and B signaling 159
Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia 158
Glioblastoma, IDH-Wild Type With FGFR3-TACC3 Fusion: When Morphology May Reliably Predict the Molecular Profile of a Tumor. A Case Report and Literature Review 157
Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts 155
Diagnostic methods and therapeutic options of uveal melanoma with emphasis on MR imaging—Part I: MR imaging with pathologic correlation and technical considerations 153
Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice 153
A population-based study of chronic myeloid leukemia patients treated with imatinib in first line 148
AN INSERTION IN THE BCR-ABL KINASE DOMAIN CONTRIBUTES TO IMATINIB MESYLATE RESISTANCE 146
BCR-ABL TYROSINE KINASE ACTIVITY MODULATES THE PHOSPHORYLATION, LOCALIZATION AND FUNCTION OF INTERFERON REGULATORY FACTOR 5 (IRF-5) IN CHRONIC MYELOID LEUKEMIA CELLS 146
An Optimized Workflow to Evaluate Estrogen Receptor Gene Mutations in Small Amounts of Cell-Free DNA 146
Diagnostic utility of the immunohistochemical expression of serin and arginine rich splicing factor 1 (Srsf1) in the differential diagnosis of adult gliomas 146
Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells 145
Histopathologic and mr imaging appearance of spontaneous and radiation-induced necrosis in uveal melanomas: Initial results 145
Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.Cancer Res 143
The Q-LAMP Method Represents a Valid and Rapid Alternative for the Detection of the BCR-ABL1 Rearrangement in Philadelphia-Positive Leukemias 143
Abemaciclib pharmacology and interactions in the treatment of HR+/HER2− breast cancer: a critical review 142
BCR-ABL Tyrosine Kinase Activity Modulates the Phosphorylation, Localization and Function of Interferon Regulatory Factor 5 (irf-5) in Chronic Myeloid Leukemia (CML) Cells 142
BCR-ABL tyrosine kinase activity modulates the phosphorylation and the localization of Interferon Regulatory Factor 5 (IRF-5)in Chronic Myeloid Leukemia cells 141
Diagnostic methods and therapeutic options of uveal melanoma with emphasis on MR imaging—Part II: treatment indications and complications 141
Knockout Serum Replacement Promotes Cell Survival by Preventing BIM from Inducing Mitochondrial Cytochrome C Release 140
Increased thyroid cancer incidence in volcanic areas: A role of increased heavy metals in the environment? 140
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery 140
Concentration of Metals and Trace Elements in the Normal Human and Rat Thyroid: Comparison with Muscle and Adipose Tissue and Volcanic Versus Control Areas 139
BCR-ABL residues interacting with ponatinib are critical to preserve the tumorigenic potential of the oncoprotein 137
New insights in thyroid cancer and p53 family proteins 137
DeltaNp73alpha inhibits PTEN expression in thyroid cancer cells 135
Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma 135
Mechanistic Translation of Melanoma Genetic Landscape in Enriched Pathways and Oncogenic Protein-Protein Interactions 135
Insulin receptor isoforms differently regulate cell proliferation and apoptosis in the ligand‐occupied and unoccupied state 133
Heavy Metals in the Environment and Thyroid Cancer 132
Next generation sequencing in a cohort of patients with rare sarcoma histotypes: A single institution experience 132
Orbital metastasis from thyroid cancer: a case report and review of the literature 131
Heavy metals in the volcanic environment and thyroid cancer 131
Immunoexpression of p62/SQSTM1/Sequestosome-1 in human primary and recurrent IDH1/2 wild-type glioblastoma: A pilot study 130
ENDOMETRIAL STROMAL TUMOR (SARCOMA) WITH LIMITED MIOMETRIAL INFILTRATION: A RARE CASE WITH PELVI-PERITONEAL METASTASES 130
The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer 130
BCR-ABL TYROSINE KINASE ACTIVITY MODULATES THE PHOSPHORYLATION, LOCALIZATION AND BIOLOGICAL FUNCTION OF INTERFERON REGULATORY FACTOR 5 IN CHRONIC MYELOID LEUKEMIA CELLS 129
Molecular Analysis of Luminal Androgen Receptor Reveals Activated Pathways and Potential Therapeutic Targets in Breast Cancer 127
Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP 127
Long-Term Molecular Remission Achieved by Antibody Anti-CD22 and Ponatinib in a Patient Affected by Ph'+ Acute Lymphoblastic Leukemia Relapsed after Second Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report 127
BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint. 126
Giant Paratesticular Liposarcoma: Molecular Characterization and Management Principles with a Review of the Literature 125
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias 125
Combined inhibition of bcl2 and bcr-abl1 exercises anti-leukemia activity but does not eradicate the primitive leukemic cells 125
Mr imaging–pathologic correlation of uveal melanomas undergoing secondary enucleation after proton beam radiotherapy 125
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy 124
Differences among young adults, adults and elderly chronic myeloid leukemia patients 123
Navigating the Nexus: HIV and Breast Cancer—A Critical Review 122
BCR-Abl tyrosine kinase activity modulates the expression of Interferon Regulatory Factor-5 in CML cells 122
Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients 122
Cerebellar liponeurocytoma: clinical, histopathological and molecular features of a series of three cases, including one recurrent tumor 122
A new kid on the block: Sacituzumab govitecan for the treatment of breast cancer and other solid tumors 120
Glucose-dependent effect of insulin receptor isoforms on tamoxifen antitumor activity in estrogen receptor-positive breast cancer cells 119
High BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability 118
A Multiplex Assay for Fast PIK3CA Hotspot Mutation Characterization in a Single Specimen by 3-Color Digital PCR Analysis 118
Biological effects of insulin and its analogs on cancer cells with different insulin family receptor expression 118
BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint 117
Early occurrence of a thyroid carcinoma in a patient who developed Graves’ disease after treatment for Hodgkin’s disease 117
A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine 117
The Consistency and Quality of ChatGPT Responses Compared to Clinical Guidelines for Ovarian Cancer: A Delphi Approach 116
Potential Therapeutic Targets for Luminal Androgen Receptor Breast Cancer: What We Know so Far 116
BCR-ABLIS Expression at Diagnosis and After 3 or 6 Months of Treatment Predicts CML Response to IMATINIB Therapy 116
BCR-ABL tyrosine kinase activity modulates survivin expression via PI3K/AKT 116
BCR-ABL tyrosine kinase activity modulates Survivin expression in CML cells 111
Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma 111
Uncommon long-term survival in a patient with chronic myeloid leukemia 110
Computational and Experimental Characterization of Two Nuclear Localization Signals and a Nuclear Export Signal that modulate BCR intracellular localization 110
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma 110
Suppression of survivin induced by BCR-ABL/JAK2/STAT3 pathway sensitizes imatinib-resistant CML cells to different cytotoxic drugs 109
c-IAP1, Survivin and Smac contribute to chemotherapy resistance in undifferentiated thyroid cancer cells 109
Molecular pathogenesis and treatment perspectives for hypereosinophilia and hypereosinophilic syndromes 109
Prospective Validation of the Italian Alliance Against Cancer Lung Panel in Patients With Advanced Non-Small-Cell Lung Cancer 107
Abemaciclib-associated Diarrhea: An Exploratory Analysis of Real-life Data 107
The optimal timing between neoadjuvant therapy and surgery of breast cancer: a brief systematic review of the literature 106
Vg9Vd2 T Lymphocytes Efficiently Recognize and Kill Zoledronate-Sensitized, Imatinib-Sensitive, and Imatinib-Resistant Chronic Myelogenous Leukemia Cells 106
No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the BCR::ABL1 Transcript Level 104
Hypoxia Induces Imatinib Resistance in CML Cell Lines 103
Multiple primary malignances managed with surgical excision: a case report with next generation sequencing analysis 103
Detection of tumor-derived extracellular vesicles in plasma from patients with solid cancer 102
Unsuccessful dasatinib therapy in a refractory patient with chronic lymphocytic leukemia 102
Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients 102
Early Gastrointestinal Progression to Immunotherapy in Lung Cancer: A Report of Two Cases 102
Totale 13.879
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.906
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.906
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021272 0 0 0 0 0 0 0 0 0 0 185 87
2021/20221.496 155 202 22 20 229 37 223 49 136 28 56 339
2022/20232.775 228 144 58 296 208 462 32 540 633 20 94 60
2023/20241.443 108 220 52 78 76 257 34 86 10 67 268 187
2024/20255.951 159 869 311 258 1.148 686 255 185 364 460 780 476
2025/202611.506 736 720 2.065 771 1.823 2.473 1.368 251 560 622 117 0
Totale 25.857